Literature DB >> 10874636

A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants.

Y V Voznyi1, J L Keulemans, G M Mancini, C E Catsman-Berrevoets, E Young, B Winchester, W J Kleijer, O P van Diggelen.   

Abstract

Palmitoyl-protein thioesterase (PPT) deficiency was recently shown to be the primary defect in infantile neuronal ceroid lipofuscinosis (INCL). The available enzyme assay is complicated and impractical for diagnostic use and is, in practice, unavailable. We have developed a new fluorimetric assay for PPT based on the sensitive fluorochrome 4-methylumbelliferone. This PPT assay is simple, sensitive, and robust and will facilitate the definition of the full clinical spectrum associated with a deficiency of PPT. PPT activity was readily detectable in fibroblasts, leucocytes, lymphoblasts, amniotic fluid cells, and chorionic villi, but was profoundly deficient in these tissues from INCL patients. Similarly, a deficiency of PPT was shown in patients with the variant juvenile NCL with GROD. These results show that rapid pre- and postnatal diagnosis can be performed with this new enzyme assay for PPT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10874636      PMCID: PMC1734393     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Towards quality assurance in the determination of lysosomal enzymes: a two-centre study.

Authors:  Z Lukacs; A Keil; V Peters; A Kohlschütter; G F Hoffmann; M Cantz; J Kopitz
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 2.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

3.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice.

Authors:  P Gupta; A A Soyombo; A Atashband; K E Wisniewski; J M Shelton; J A Richardson; R E Hammer; S L Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 4.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

5.  The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis.

Authors:  Jake N Miller; Chun-Hung Chan; David A Pearce
Journal:  Hum Mol Genet       Date:  2013-03-28       Impact factor: 6.150

6.  The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.

Authors:  Jake N Miller; Attila D Kovács; David A Pearce
Journal:  Hum Mol Genet       Date:  2014-09-08       Impact factor: 6.150

Review 7.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

8.  Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B.

Authors:  Malia B Potts; Elizabeth A McMillan; Tracy I Rosales; Hyun Seok Kim; Yi-Hung Ou; Jason E Toombs; Rolf A Brekken; Mark D Minden; John B MacMillan; Michael A White
Journal:  Nat Chem Biol       Date:  2015-04-13       Impact factor: 15.040

9.  Analysis of NCL Proteins from an Evolutionary Standpoint.

Authors:  Neda E Muzaffar; David A Pearce
Journal:  Curr Genomics       Date:  2008-04       Impact factor: 2.236

10.  Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL.

Authors:  Vaughn Thada; Jake N Miller; Attila D Kovács; David A Pearce
Journal:  J Cell Mol Med       Date:  2015-12-09       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.